0000930413-12-000231.txt : 20120119 0000930413-12-000231.hdr.sgml : 20120119 20120119184823 ACCESSION NUMBER: 0000930413-12-000231 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111117 FILED AS OF DATE: 20120119 DATE AS OF CHANGE: 20120119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stancic Ana CENTRAL INDEX KEY: 0001320271 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 12535581 MAIL ADDRESS: STREET 1: CHAMPIONS BIOTECHNOLOGY, INC. STREET 2: 855 NORTH WOLFE STREET, SUITE 619 CITY: BALTIMORE STATE: MD ZIP: 21205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD STREET 2: ATT: GENERAL COUNSEL CITY: PISCATAWAY STATE: NJ ZIP: 08854 BUSINESS PHONE: 732-980-4500 MAIL ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD STREET 2: ATT: GENERAL COUNSEL CITY: PISCATAWAY STATE: NJ ZIP: 08854 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4/A 1 c68180_4a.xml OWNERSHIP DOCUMENT X0304 4/A 2011-11-17 2011-11-21 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001320271 Stancic Ana C/O ENZON PHARMACEUTICALS, INC. 20 KINGSBRIDGE ROAD PISCATAWAY NJ 08854 0 1 0 0 Executive VP, COO, PEO CFO Employee Stock Option (Right to Buy) 6.37 2011-11-17 4 A 0 125000 0 A 2021-11-17 Common Stock 125000 125000 D Options granted by the Issuer pursuant to its 2011 Stock Option and Incentive Plan and qualified under Rule 16b-3(d). The options will vest in four (4) tranches. Of the 125,000 options granted, 31,250 options will vest on November 17, 2012, 31,250 options will vest on November 17, 2013, 31,250 options will vest on November 17, 2014, and the remaining 31,250 options will vest on November 17, 2015, in each case if the Reporting Person remains employed by the Issuer on such date. The Reporting Person's Form 4 filed on November 21, 2011 incorrectly reported that the expiration date of the stock options was November 17, 2011. The Reporting Person's Form 4 filed on November 21, 2011 incorrectly reported that the Reporting Person beneficially owned 155,000 of the subject stock options. /s/ Andrew Rackear, Attorney-in-Fact 2012-01-19